v3.25.2
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
 [1]
Accumulated Other Comprehensive Income
Accumulated Deficit
 [1]
Total
Balance at Dec. 31, 2023 $ 2 $ 30,908 $ 12 $ (33,071) $ (2,149)
Balance (in Shares) at Dec. 31, 2023 16,294,935        
Stock-based compensation 283 283
Sale of common stock 2,605 2,605
Sale of common stock (in Shares) 1,187,398        
Cumulative translation adjustment (2) (2)
Net income (loss) (3,205) (3,205)
Balance at Mar. 31, 2024 $ 2 33,796 10 (36,276) (2,468)
Balance (in Shares) at Mar. 31, 2024 17,482,333        
Balance at Dec. 31, 2023 $ 2 30,908 12 (33,071) (2,149)
Balance (in Shares) at Dec. 31, 2023 16,294,935        
Net income (loss)         (6,069)
Balance at Jun. 30, 2024 $ 2 34,423 10 (39,140) (4,705)
Balance (in Shares) at Jun. 30, 2024 17,606,367        
Balance at Mar. 31, 2024 $ 2 33,796 10 (36,276) (2,468)
Balance (in Shares) at Mar. 31, 2024 17,482,333        
Stock-based compensation 402 402
Issuance of common stock under the SEPA 225 225
Issuance of common stock under the SEPA (in Shares) 94,937        
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 29,097        
Cumulative translation adjustment
Net income (loss) (2,864) (2,864)
Balance at Jun. 30, 2024 $ 2 34,423 10 (39,140) (4,705)
Balance (in Shares) at Jun. 30, 2024 17,606,367        
Balance at Dec. 31, 2024 $ 2 40,973 3 (48,229) (7,251)
Balance (in Shares) at Dec. 31, 2024 22,594,877        
Stock-based compensation 200 200
Issuance of common stock from debt offering 377 377
Issuance of common stock from debt offering (in Shares) 2,028,846        
Issuance of common stock to pay convertible debt 1,433 1,433
Issuance of common stock to pay convertible debt (in Shares) 610,426        
Sale of common stock   543 543
Sale of common stock (in Shares) 310,925        
Exercise of stock options   158 158
Exercise of stock options (in Shares) 43,047        
Cumulative translation adjustment 17 17
Net income (loss) 2,897 2,897
Balance at Mar. 31, 2025 $ 2 43,684 20 (45,332) (1,626)
Balance (in Shares) at Mar. 31, 2025 25,588,121        
Balance at Dec. 31, 2024 $ 2 40,973 3 (48,229) (7,251)
Balance (in Shares) at Dec. 31, 2024 22,594,877        
Net income (loss)         (5,071)
Balance at Jun. 30, 2025 $ 2 44,095 52 (53,300) (9,151)
Balance (in Shares) at Jun. 30, 2025 25,737,820        
Balance at Mar. 31, 2025 $ 2 43,684 20 (45,332) (1,626)
Balance (in Shares) at Mar. 31, 2025 25,588,121        
Stock-based compensation 411 411
Vesting of restricted stock units
Vesting of restricted stock units (in Shares) 109,699        
Issuance of common stock from debt offering
Issuance of common stock from debt offering (in Shares) 40,000        
Cumulative translation adjustment 32 32
Net income (loss) (7,968) (7,968)
Balance at Jun. 30, 2025 $ 2 $ 44,095 $ 52 $ (53,300) $ (9,151)
Balance (in Shares) at Jun. 30, 2025 25,737,820        
[1] Reflects an adjustment of $126,000 as compared to previously reported amounts as of December 31, 2024. Reflects an adjustment of $(157,000) in Additional Paid in Capital and $283,000 in Accumulated Deficit as of December 31, 2023. See further discussion in Note 1.